UK-based Evonetix Ltd has appointed Colin McCracken as chief executive ahead of the launch of its first product, a benchtop DNA printer. Mr McCracken joins from Fluidigm Corp, a manufacturer of microfluidic devices, where he was responsible for commercial activities. He has also held leadership positions at Thermo Fisher Scientific Corp, Life Technologies Corp and Qiagen NV.
Evonetix announced the appointment on 13 June 2022.
Copyright 2022 Evernow Publishing Ltd